This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Harmony Biosciences’s 8K filing here.
Harmony Biosciences Company Profile
Harmony Biosciences Holdings, Inc, a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy.
Featured Articles
- Five stocks we like better than Harmony Biosciences
- Canada Bond Market Holiday: How to Invest and Trade
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Consumer Discretionary Stocks Explained
- MarketBeat Week in Review – 01/13 – 01/17
